Stress and stress-induced disorders in children
https://doi.org/10.21518/2079-701X-2018-11-110-116
Abstract
Stress is one of the main reasons for the exponential growth of most chronic non-infectious diseases. The stress response is a genetically determined nonspecific adaptive mechanism. However, if it is an overly intense and prolonged, it becomes a risk factor for the pathogenesis of cardiovascular and oncological diseases, immunodeficiencies, digestive tract diseases and other pathological conditions. Studies have shown that magnesium deficiency, which develops against the background of stress, repeatedly intensifies its negative manifestations. Magnesium preparations make up the basis of therapeutic and rehabilitation activities in children experiencing stress. Timely correction of magnesium deficiency can increase the resistance against the action of stressors, neutralize or mitigate their damaging effect, and also prevent the development of stress-induced pathology.
About the Authors
I. N. Zakharova
Russian Medical Academy of Continuing Postgraduate Education, FGBOU DPO of the Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
T. M. Tvorogova
Russian Medical Academy of Continuing Postgraduate Education, FGBOU DPO of the Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
I. I. Pshenichnikova
Russian Medical Academy of Continuing Postgraduate Education, FGBOU DPO of the Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
V. I. Svintsitskaya
Russian Medical Academy of Continuing Postgraduate Education, FGBOU DPO of the Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
L. L. Stepurina
Russian Medical Academy of Continuing Postgraduate Education, FGBOU DPO of the Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
References
1. Yusuf S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet, 2004, 364(9438): 937-952.
2. Nielsen KM et al. Danish singles have a twofold risk of acute coronary syndrome: data from a cohort of 138 290 persons. Journal of Epidemiology & Community Health, 2006, 60(8): 721-728.
3. Netterstrøm B, Kristensen TS, Sjøl A. Psychological job demands increase the risk of ischaemic heart disease: a 14-year cohort study of employed Danish men. European Journal of Cardiovascular Prevention & Rehabilitation, 2006, 13(3): 414-420.
4. Yunusova SG, Rosenthal AN, Baltina ТV. Stress. Biological and psychological aspects. Uchenye Zapiski Kazanskogo Universiteta. Seriya Gumanitarnye Nauki, 2008, 150 (3).
5. Barkovskaya AYu, Nazarova MP. Stress factors in the sociocultural space of a modern big city. Primo Aspectu, 2014, 16 (5): 37-42.
6. Kino T, Charmandari E, Chrousos GP. Disorders of the Hypothalamic-Pituitary-Adrenocortical System. Handbook of Neuroendocrinology, 2012: 639-657.
7. Shastun SA, Agadjanyan NA, Ignatiev AV. Features of the processes of free radical oxidation of blood in people with different levels of physical performance. Vestnik RUDN. Seriya: Medicina, 2002, 3.
8. Eiden LE. Neuropeptide-catecholamine interactions in stress. Advances in Pharmacology. Academic Press, 2013, 68: 399-404.
9. Oganov RG, Pogosova GV. Stress: what do we know about this risk factor today? Racionalnaya Farmakoterapiya v Kardiologii, 2007, 3 (30).
10. Larzelere MM, Jones GN. Stress and health. Primary Care: Clinics in Office Practice, 2008, 35(4): 839-856.
11. Vorobyeva OV. Stress and adjustment disorders. RMJ, 2009, 17 (11): 789-793.
12. Gromova OA et al. Magnesium deficiency as a problem of stress and disadaptation in children. RMJ, 2012, 20 (16): 813-821.
13. Landfield PW et al. A new glucocorticoid hypothesis of brain aging: implications for Alzheimer’s disease. Current Alzheimer Research, 2007, 4(2): 205-212.
14. Parati G, Molinary E. Clinical psychology and heart disease. 2010.
15. Tamashiro KL et al. Chronic stress, metabolism, and metabolic syndrome. Stress, 2011, 14(5): 468-474.
16. Dhabhar FS. Effects of stress on immune function: the good, the bad, and the beautiful. Immunologic research, 2014, 58(2-3): 193-210.
17. Sharpe KH et al. Association between socioeconomic factors and cancer risk: a population cohort study in Scotland (1991-2006). PLoS One, 2014, 9(2): e89513.
18. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology, 2016, 150(6): 1262-1279.
19. Steptoe A, Kivimäki M. Stress and cardiovascular disease. Nature Reviews Cardiology, 2012, 9(6): 360.
20. Lampert R. Mental stress and ventricular arrhythmias. Current cardiology reports, 2016, 18(12): 118.
21. Richman LS et al. The relationship between mental vitality and cardiovascular health. Psychology and Health, 2009, 24(8): 919-932.
22. Oganov RG et al. The importance of cardiovascular and other non-infectious diseases for the health of population of Russia. Profilakticheskaya Medicina, 2002, 5 (2): 3-7.
23. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 1999, 99(16): 2192-2217.
24. Hansson A, Madsen-Härdig B, Olsson SB. Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: a study based on interviews with 100 patients seeking hospital assistance. BMC cardiovascular disorders, 2004, 4(1): 13.
25. Cohen BE et al. Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: findings from the Heart and Soul Study. Psychiatry research, 2010, 175(1): 133-137.
26. Kiecolt-Glaser JK et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proceedings of the national Academy of Sciences, 2003, 100(15): 9090-9095.
27. Mocci F et al. The effect of noise on serum and urinary magnesium and catecholamines in humans. Occupational Medicine, 2001, 51(1): 56-61.
28. Grases G et al. Anxiety and stress among science students. Study of calcium and magnesium alterations. Magnesium research, 2006, 19(2): 102-106.
29. Jacka FN et al. Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. Australian & New Zealand Journal of Psychiatry, 2009, 43(1): 45-52.
30. Billyard AJ, Eggett DL, Franz KB. Dietary magnesium deficiency decreases plasma melatonin in rats. Magnesium research, 2006, 19(3): 157-161.
31. Abbasi B et al. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences, 2012, 17(12): 1161.
32. Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Alternative Medicine Review, 2000, 5(2): 93-108.
33. Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnesium research, 2004, 17(2): 126-136.
34. Nielsen FH. Magnesium, inflammation, and obesity in chronic disease. Nutrition reviews, 2010, 68(6): 333-340.
35. Guerrero‐Romero F, Rodríguez‐Morán M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes/metabolism research and reviews, 2006, 22(6): 471-476.
36. Maier JAM et al. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 2004, 1689(1): 13-21.
37. Takase B et al. Effect of chronic stress and sleep deprivation on both flow‐mediated dilation in the brachial artery and the intracellular magnesium level in humans. Clinical cardiology, 2004, 27(4): 223-227.
38. Champagne CM. Magnesium in hypertension, cardiovascular disease, metabolic syndrome, and other conditions: a review. Nutrition in Clinical Practice, 2008, 23(2): 142-151.
39. Gums JG. Magnesium in cardiovascular and other disorders. American journal of health-system pharmacy, 2004, 61(15): 1569-1576.
40. De Lenardis M, Schindler R, Classen HG. Hypomagnesemia and suboptimal plasma-Mg levels in diabetes mellitus: frequencies and consequences. Magnesium-bulletin, 2000, 22(3): 53-59.
41. Kalacheva AG. Element-specific indicators of neurotropic functions of magnesium. Moscow, 2011. P. 23.
42. Hänni A. Magnesium and the insulin resistance syndrome: дис. Acta Universitatis Upsaliensis, 2001.
43. Held K et al. Oral Mg2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry, 2002, 35(04): 135-143.
44. Kalinin VV, et al. The use of Magne-B6 for the treatment of anxiety-depressive states in patients with epilepsy. Zhurnal Nevrologii i Psihiatrii Im. C.C. Korsakova, 2004, 104 (8): 51-55.
45. Veyn AM, Solovyeva AD, Akarachkova YeS. Magne B6 in the treatment of autonomic dystonia syndrome. Lechenie nervnykh bolezney, 2003, 4 (2): 10.
46. Gromova OA, et al. Molecular mechanisms of magnesium pidolate and its neurotropic effects. Zhurnal Nevrologii i Psikhiatrii, 2016, 12: 96-103
Review
For citations:
Zakharova IN, Tvorogova TM, Pshenichnikova II, Svintsitskaya VI, Stepurina LL. Stress and stress-induced disorders in children. Meditsinskiy sovet = Medical Council. 2018;(11):110-116. (In Russ.) https://doi.org/10.21518/2079-701X-2018-11-110-116
Views:
893
Email this article 